In a letter sent to the committee by assistant engineer of BMC’s F/South ward it has been mentioned that during the routine inspection 36 potholes were found by the authorities.
MyJournals.org - Science - Pharmaceuticals, Vol. 16, Pages 749: S-72, A Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer (Pharmaceuticals)
SINGAPORE, April 14 After unsuccessful attempts at bidding for projects from Wildlife Reserves Singapore (WRS), a company director decided to bribe his way to get some.
Den Networks consolidated net profit surged 50.5% to Rs 33.89 crore on a 0.5% decline in net sales to Rs 326.23 crore in Q4 FY21 over Q4 FY20.
On a consolidated basis, subscription revenues fell 15% to Rs 190 crore and activation revenues surged 63% to Rs 34 crore in Q4 FY21 over Q4 FY20.
EBITDA rose 2% to Rs 65 crore in Q4 FY21 from Rs 64 crore in Q4 FY20. EBITDA margin stood at 20% in Q4 FY21 over 19% in Q4 FY20. As on Q4 FY21, cash and cash equivalents stood at Rs 2,394 crore.
During the year ended 31 March 2019, Den Networks allotted on preferertial basis 28.14 crore equity shares of Rs 72.66 each, at a premium of Rs 62.66 per share aggregating to Rs 2,045 crore. The proceeds of peferential allotment amounting to Rs 2,045 crore have been temporarily invested in liquid mutual funds and fixed deposits, pending utilisation for same.